<html>
<head>PUBMED IDs for BCR2</head>
<body bgcolor='#C5F0F2'><h1>BCR2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/3118359/'>Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints.</a> October 1  1987<br><a href='https://pubmed.ncbi.nlm.nih.gov/8393238/'>An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.</a> August 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/8178450/'>Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions.</a> May 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/9628332/'>Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing.</a> June 17  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10861294/'>DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.</a> June 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12619163/'>Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.</a> March 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/26797972/'>Direct Detection of Burkholderia cepacia in Susceptible Pharmaceutical Products Using Semi-Nested PCR.</a> January 23  2016<br></body></html>
